BLOOD AND TISSUE IMMUNOPHENOTYPING IN CANCER PATIENTS TREATED WITH ANTI-GALECTIN-9 MONOCLONAL ANTIBODY (LYT-200) ALONE AND IN COMBINATION WITH ANTI-PD1

Puretech Health Llc

Investigators